Her primary scientific interests are in Mesenchymal stem cell, Cell biology, Stem cell, Microvesicles and Pathology. Stefania Bruno interconnects Cell and Paracrine signalling in the investigation of issues within Mesenchymal stem cell. Her Cell biology study often links to related topics such as Immunology.
In her research on the topic of Stem cell, Stem cell marker is strongly related with Adult stem cell. Her work on Microvesicle and Exosome as part of general Microvesicles research is frequently linked to Angiogenesis, Reprogramming and Cell growth, thereby connecting diverse disciplines of science. Her studies deal with areas such as Apoptosis, Cancer research, Kidney and CD44 as well as Pathology.
Her primary areas of study are Stem cell, Cell biology, Mesenchymal stem cell, Microvesicles and Pathology. Her study in Stem cell is interdisciplinary in nature, drawing from both Molecular biology, Immunology, Cord blood and Adult stem cell. While the research belongs to areas of Cell biology, Stefania Bruno spends her time largely on the problem of Angiogenesis, intersecting her research to questions surrounding Cell cycle.
Stefania Bruno usually deals with Mesenchymal stem cell and limits it to topics linked to Stem cell transplantation for articular cartilage repair and Clinical uses of mesenchymal stem cells. In general Microvesicles study, her work on Exosome and Microvesicle often relates to the realm of Cancer research, Regenerative medicine and Reprogramming, thereby connecting several areas of interest. She has researched Pathology in several fields, including Acute kidney injury, Flow cytometry and Amniotic epithelial cells.
Her main research concerns Cell biology, Stem cell, Mesenchymal stem cell, Inflammation and Microvesicles. Her work carried out in the field of Cell biology brings together such families of science as Cell, In vitro and Nucleic acid. Her studies deal with areas such as Cancer research, Liver transplantation, Paracrine signalling and Liver regeneration as well as Stem cell.
Her Mesenchymal stem cell study combines topics from a wide range of disciplines, such as Stromal cell, Extracellular vesicles, Cell therapy and Regeneration. Her Inflammation study incorporates themes from Fibrosis, Liver function, Pharmacology and Pathogenesis. Stefania Bruno does research in Microvesicles, focusing on Exosome specifically.
Her primary areas of investigation include Stem cell, Mesenchymal stem cell, Cell biology, In vitro and Microvesicles. Stefania Bruno interconnects Liver function, Cell type and Cancer research in the investigation of issues within Stem cell. Her work carried out in the field of Mesenchymal stem cell brings together such families of science as Stromal cell and Extracellular vesicles.
Her biological study spans a wide range of topics, including Microglia, Computational biology, Neuroprotection and Ischemia. Stefania Bruno combines subjects such as Cellular origin, Kidney, Transfection and Regeneration with her study of In vitro. Paracrine Communication, Nucleic acid, Cancer cell, Extracellular and Signal transduction are fields of study that overlap with her Microvesicles research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular Injury
Stefania Bruno;Cristina Grange;Maria Chiara Deregibus;Raffaele A. Calogero.
Journal of The American Society of Nephrology (2009)
Exosomes/microvesicles as a mechanism of cell-to-cell communication
Giovanni Camussi;Maria C Deregibus;Stefania Bruno;Vincenzo Cantaluppi.
Kidney International (2010)
Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA.
Maria Chiara Deregibus;Vincenzo Cantaluppi;Raffaele Calogero;Marco Lo Iacono.
Blood (2007)
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.
Aravinthan Varatharaj;Aravinthan Varatharaj;Naomi Thomas;Mark A Ellul;Mark A Ellul;Mark A Ellul;Nicholas W S Davies.
The Lancet Psychiatry (2020)
Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury
Stefano Gatti;Stefania Bruno;Maria Chiara Deregibus;Andrea Sordi.
Nephrology Dialysis Transplantation (2011)
Isolation of Renal Progenitor Cells from Adult Human Kidney
Benedetta Bussolati;Stefania Bruno;Cristina Grange;Stefano Buttiglieri.
American Journal of Pathology (2005)
Microvesicles Derived from Adult Human Bone Marrow and Tissue Specific Mesenchymal Stem Cells Shuttle Selected Pattern of miRNAs
Federica Collino;Maria Chiara Deregibus;Stefania Bruno;Luca Sterpone.
PLOS ONE (2010)
Microvesicles Derived from Mesenchymal Stem Cells Enhance Survival in a Lethal Model of Acute Kidney Injury
Stefania Bruno;Cristina Grange;Federica Collino;Maria Chiara Deregibus.
PLOS ONE (2012)
Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury
Maria Beatriz Herrera;Benedetta Bussolati;Stefania Bruno;Valentina Fonsato.
International Journal of Molecular Medicine (2004)
Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia–reperfusion injury by microRNA-dependent reprogramming of resident renal cells
Vincenzo Cantaluppi;Stefano Gatti;Davide Medica;Federico Figliolini.
Kidney International (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Turin
University of Turin
University of Turin
University of Turin
Brown University
University of Turin
University of Turin
University of Turin
University of Porto
University of Liverpool
University of Illinois at Urbana-Champaign
University of Central Florida
University of Minnesota
Verizon (United States)
National Institute of Standards and Technology
University of Nevada, Reno
RIKEN Center for Integrative Medical Sciences
National Taiwan University
University of Iceland
Beijing Normal University
National Institutes of Health
Karolinska Institute
RMIT University
University of Turin
Durham University
Durham University